Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Rae

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|December 15, 2021
The role of estrogen receptor signaling in suppressing the immune response to cancerJames M Rae, Marc E Lippman
Journal of the National Cancer Institute|April 5, 2014
ResponseJames M Rae, Brian Leyland-Jones, Meredith Regan
Oncology (Williston Park, N.Y.)|February 4, 2010
CYP2D6 testing for breast cancer patients: is there more to the story?N Lynn Henry, Daniel F Hayes, James M Rae
Hormones & Cancer|March 13, 2016
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate CancerCameron P Capper, James M Rae, Richard J Auchus
Pharmacogenomics|March 28, 2017
Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patientsDaniel L Hertz, N Lynn Henry, James M Rae
Toxicology|April 4, 2019
Implication of environmental estrogens on breast cancer treatment and progressionThomas L Gonzalez, James M Rae, Justin A Colacino
Transactions of the American Clinical and Climatological Association|July 4, 2008
An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor statusMarc E Lippman, James M Rae, Arul M Chinnaiyan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolismJames M Rae, Nadia V Soukhova, David A Flockhart, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Journal of the National Cancer Institute|March 28, 2015
Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesJames M Rae, Brian Leyland-Jones, Meredith Regan, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|December 15, 2021
The role of estrogen receptor signaling in suppressing the immune response to cancerJames M Rae, Marc E Lippman
Journal of the National Cancer Institute|April 5, 2014
ResponseJames M Rae, Brian Leyland-Jones, Meredith Regan
Oncology (Williston Park, N.Y.)|February 4, 2010
CYP2D6 testing for breast cancer patients: is there more to the story?N Lynn Henry, Daniel F Hayes, James M Rae
Hormones & Cancer|March 13, 2016
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate CancerCameron P Capper, James M Rae, Richard J Auchus
Pharmacogenomics|March 28, 2017
Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patientsDaniel L Hertz, N Lynn Henry, James M Rae
Toxicology|April 4, 2019
Implication of environmental estrogens on breast cancer treatment and progressionThomas L Gonzalez, James M Rae, Justin A Colacino
Transactions of the American Clinical and Climatological Association|July 4, 2008
An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor statusMarc E Lippman, James M Rae, Arul M Chinnaiyan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolismJames M Rae, Nadia V Soukhova, David A Flockhart, et al.
Breast Cancer Research : BCR|January 30, 2008
The role of single nucleotide polymorphisms in breast cancer metastasisJames M Rae, Todd C Skaar, Susan G Hilsenbeck, et al.
Journal of the National Cancer Institute|March 28, 2015
Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesJames M Rae, Brian Leyland-Jones, Meredith Regan, et al.
Pageof 13